2012Jiangsu Medical JournalRequires access

Efficacy of benazepril combined with leflunomide in treatment of IgA nephropathy

Sun Don

Open publisher page 2 citations

Abstract

Objective To investigate the clinical efficacy of benazepril combined with leflunomide in treating IgA nephropathy.Methods Sixty patients with IgA nephropathy were equally randomized into two groups of A(treated with benazepril 10 mg/d combined with leflunomide 20 mg/d for 6 months) and B(treated with benazepril for 6 months).Clinical efficacy was compared between two groups.Results The total effectiveness rate of group A was 83.3%,which was higher than 66.7% of group B(P0.05).After treatment,urine protein was lower in group A than that in group B(0.62±0.24) g/24 h vs.(1.62±0.46) g/24 h and serum albumin was higher in group A than that in group B(40.36±10.32) g/L vs.(32.86±10.31) g/L(P0.05).Conclusion Benazepril combined with leflunomide can effectively increase serum albumin and reduce urine protein of patients with IgA nephropathy.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of benazepril combined with leflunomide in treating IgA nephropathy.Methods Sixty patients with IgA nephropathy were equally randomized into two groups of A(treated with benazepril 10 mg/d combined with leflunomide 20 mg/d for 6 months) and B(treated with benazepril for 6 months).Clinical efficacy was compared between two groups.Results The total effectiveness rate of group A was 83.3%,which was higher than 66.7% of group B(P0.05).After treatment,urine protein was lower in group A than that in group B(0.62±0.24) g/24 h vs.(1.62±0.46) g/24 h and serum albumin was higher in group A than that in group B(40.36±10.32) g/L vs.(32.86±10.31) g/L(P0.05).Conclusion Benazepril combined with leflunomide can effectively increase serum albumin and reduce urine protein of patients with IgA nephropathy.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of benazepril combined with leflunomide in treating IgA nephropathy.Methods Sixty patients with IgA nephropathy were equally randomized into two groups of A(treated with benazepril 10 mg/d combined with leflunomide 20 mg/d for 6 months) and B(treated with benazepril for 6 months).Clinical efficacy was compared between two groups.Results The total effectiveness rate of group A was 83.3%,which was higher than 66.7% of group B(P0.05).After treatment,urine protein was lower in group A than that in group B(0.62±0.24) g/24 h vs.(1.62±0.46) g/24 h and serum albumin was higher in group A than that in group B(40.36±10.32) g/L vs.(32.86±10.31) g/L(P0.05).Conclusion Benazepril combined with leflunomide can effectively increase serum albumin and reduce urine protein of patients with IgA nephropathy.

Key concepts: Benazepril, Leflunomide, Medicine, Urine, Nephropathy, Group B, Gastroenterology, Group A

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of benazepril combined with leflunomide in treatment of IgA nephropathy — Research Paper | ScholarLens